Micro Cap Stock News Hubb
Advertisement Banner
  • Home
  • News
  • Stocks & Capital News
  • Contact
No Result
View All Result
  • Home
  • News
  • Stocks & Capital News
  • Contact
No Result
View All Result
Wellnessnewshubb
No Result
View All Result
Home Stocks & Capital News

This fund beats the S&P 500 by using 75 of its stocks. Here’s how it works.

admin by admin
December 10, 2022
in Stocks & Capital News


What worked well during the years-long bull market through 2021 — a focus on growth, regardless of price — has ground to a halt this year. The rebirth of the value style of investing — and modest valuations overall — has taken hold.

The approach taken by the Invesco S&P 500 GARP ETF has paid off through both bull and bear markets.

Let’s begin with a 10-year chart comparing total returns with dividends reinvested for the Invesco S&P 500 GARP ETF
SPGP,
-0.81%

and the SPDR S&P 500 ETF Trust
SPY,
-0.75%
,
which tracks the benchmark S&P 500:


FactSet

So far this year, SPGP is down 12%, while SPY is down 16%. But the long-term chart shows significant and consistent outperformance for SPGP, even during the bull market.

The S&P 500 GARP Index

GARP stands for “growth at a reasonable price.” SPGP tracks the S&P 500 GARP Index, which is reconstituted and rebalanced twice a year, on the third Fridays of June and December. The next change occurs Dec. 16.

S&P Dow Jones Indices assigns a growth score to each component of the S&P 500 by averaging the three-year compound annual growth rate (CAGR) for earnings and sales per share.

The top 150 components of the S&P 500 by growth score are eligible for inclusion in the GARP index. Those 150 are ranked by “quality/value composite score,” which is the average of these three ratios:

  • Financial leverage — total debt to book value.

  • Return on equity — trailing 12 months’ earnings per share divided by book value per share.

  • Earnings-to-price — 12 months’ earnings per share divided by the share price.

The top 75 of the 150 by QV rankings are then included in the GARP index and weighted by the growth score, with portfolio weightings ranging from 0.5% to 5%.

There is a weighting limitation of 40% to any one of the 11 S&P sectors.

Addressing concentration risk

The benchmark S&P 500 Index
SPX,
-0.73%

is weighted by market capitalization, which means it is more heavily concentrated than you might expect — success is rewarded, with rising stocks more heavily weighted over time.

That can backfire during a bear market, with Amazon.com Inc.
AMZN,
-1.39%

down 47% and Tesla Inc.
TSLA,
+3.23%

down 51% this year, to name two prominent examples.

Looking at the SPDR S&P 500 ETF Trust
SPY,
-0.75%
,
which is the first and largest exchange traded fund and tracks the benchmark index by holding all of its components, six companies (Apple Inc.
AAPL,
-0.34%
,
Microsoft Corp.
MSFT,
-0.80%
,
Amazon, both common share classes of Alphabet Inc.
GOOGL,
-0.94%

 
GOOG,
-0.94%

and Berkshire Hathaway Inc.
BRK.B,
+0.13%

) make up 19.2% of the portfolio.

That percentage has come down this year, but a lot of risk remains concentrated in a handful of companies. (Apple alone makes up 6.4% of the SPY portfolio. Tesla is now the ninth-largest holding, making up 1.4% of the portfolio.)

One way to address high concentration in an index fund is to use an equal-weighted approach, which Mark Hulbert recently discussed.

For the Invesco S&P 500 GARP ETF, the underlying index’s selection methodology has resulted in much less portfolio concentration than we see in SPY, with the top five holdings making up 10.9% of the portfolio.

Here are the 10 largest holdings of SPGP:

Company

Ticker

Share of portfolio

Regeneron Pharmaceuticals, Inc.

REGN,
-2.01%
2.49%

Cigna Corporation

CI,
-0.41%
2.26%

Everest Re Group, Ltd.

RE,
-0.35%
2.21%

Vertex Pharmaceuticals Incorporated

VRTX,
-2.83%
1.98%

D.R. Horton, Inc.

DHI,
-0.69%
1.97%

Expeditors International of Washington, Inc.

EXPD,
+0.06%
1.96%

Incyte Corporation

INCY,
-2.10%
1.92%

Goldman Sachs Group, Inc.

GS,
+0.30%
1.83%

Ebay Inc.

EBAY,
-0.55%
1.81%

Pfizer Inc.

PFE,
-0.12%
1.73%

Source: FactSet

Click on the tickers for more information about any company, ETF or index in this article.

You should also read Tomi Kilgore’s detailed guide to the wealth of information for free on the MarketWatch quote page.

Don’t miss: 10 Dividend Aristocrat stocks expected by analysts to rise up to 54% in 2023



Source link

Tags: article_normalAudiovisual ProductionbankingBanking/CreditBiotechnologyBuilding ConstructionbusinessBusiness/Consumer ServicesC&E Exclusion FilterC&E Executive News FiltercommentaryCommentary/OpinioncommodityCommodity/Financial Market Newsconstructionconsumer servicesContent TypescreditDiversified Holding CompaniesE-commerceEBAYeBay Inc.entertainmentEquity MarketsEtailingExchange Traded FundsFactiva FiltersFinancial Investment Servicesfinancial market newsFinancial Servicesfreight transportFreight Transport/Logisticsgeneral newsGoldman Sachs Group IncGShealthcareHealthcare/Life SciencesIndustrial GoodsInsuranceinternetInternet Search EnginesInternet/Online ServicesinvestingInvesting/SecuritiesInvestment Bankinglife scienceslogisticsmediaMedia/EntertainmentMetal ProductsnationalNational/Public Securityonline servicesopinionPersonal FinancePFEPfizer Inc.PharmaceuticalspoliticalPolitical/General Newspublic securityreal estateReal Estate/ConstructionRegeneron Pharmaceuticals IncREGNResidential Building ConstructionretailRetail/WholesalesecuritiesSPDR S&P 500 ETF TrustSPYTechnologyTelevision Program ProductiontransportationTransportation/LogisticswholesaleWholesalers
Previous Post

City Office REIT: The Preferred Shares Now Offer A 9% Yield (NYSE:CIO)

Next Post

2 of the Best Deals Around for Building Wealth in Your TFSA

Next Post

2 of the Best Deals Around for Building Wealth in Your TFSA

Recommended

Find yourself gaslighted at work? Here’s how to recognize the signs.

2 months ago

Bed Bath & Beyond, Tesla, Expedia and more

5 months ago

© Micro Cap Stocks News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Stocks & Capital News
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Stocks & Capital News
  • Contact

© 2022 Micro Cap Stock News Hubb All rights reserved.